Effect and mechanism of CyPA in radiosensitization of lung adenocarcinoma using CRISPR/Cas9 technology

Effect and mechanism of CyPA in radiosensitization of lung adenocarcinoma using CRISPR/Cas9 technology

Objective: To explore the role of cyclophilin A (CyPA) in sensitization of lung adenocarcinoma to radiotherapy using CRISPR/Cas9 technology. Methods: A CyPA knockout human lung adenocarcinoma cell line H1975 was established by CRISPR/Cas9 technology. Groups included a control group (wildtype), CyPA...

Full description

Bibliographic Details
Main Authors:	Jinkun Ma, Lin Xu, Jinchang Huang, Qiaoli Zhang, Yuqin Qiu, Xuewei Qi, Lina Wang, Yuchan Cao, Zeyu Liu, Shiyun Liu
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	Journal of Traditional Chinese Medical Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095754820300065

Similar Items

Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model
by: El-Ebidi AM, et al.
Published: (2020-10-01)

Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells
by: Yao Meng, et al.
Published: (2020-10-01)

Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis
by: Xinzhu Ni, et al.
Published: (2024-04-01)

The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
by: David Heinzmann, et al.
Published: (2015-01-01)

Genome-scale CRISPR-Cas9 knockout screening in nasopharyngeal carcinoma for radiosensitive and radioresistant genes
by: Ziyan Zhou, et al.
Published: (2023-04-01)

Structural and biochemical insights of CypA and AIF interaction
by: Biancamaria Farina, et al.
Published: (2017-04-01)

Progress of CypA and Lung Cancer-related Research
by: Zhe QIAN, et al.
Published: (2010-08-01)

CypA, a gene downstream of HIF-1α, promotes the development of PDAC.
by: Huan Zhang, et al.
Published: (2014-01-01)

CYPA, a novel and potential genetic adjuvant enhanced HIV-1 DNA vaccine immunoreactivity
by: Hou J, et al.
Published: (2012-09-01)

Evolution of a TRIM5-CypA splice isoform in old world monkeys.
by: Ruchi M Newman, et al.
Published: (2008-02-01)

LSSmScarlet, dCyRFP2s, dCyOFP2s and CRISPRed2s, Genetically Encoded Red Fluorescent Proteins with a Large Stokes Shift
by: Oksana M. Subach, et al.
Published: (2021-11-01)

Role of Autophagy in the Radiosensitivity of Human Lung Adenocarcinoma A549 Cells
by: Liyao XU, et al.
Published: (2016-12-01)

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
by: Huan-ping Long, et al.
Published: (2020-04-01)

CRISPR/Cas9-Mediated Multiplexed Genome Editing in <i>Aspergillus oryzae</i>
by: Qinghua Li, et al.
Published: (2023-01-01)

Computational Tools and Resources for CRISPR/Cas Genome Editing
by: Chao Li, et al.
Published: (2023-02-01)

Cytomulate: accurate and efficient simulation of CyTOF data
by: Yuqiu Yang, et al.
Published: (2023-11-01)

CRISPR/Cas-based Diagnostics and Gene Therapy
by: Meiyu Qiu, et al.
Published: (2021-11-01)

Application of different types of CRISPR/Cas-based systems in bacteria
by: Zhenquan Liu, et al.
Published: (2020-09-01)

Application of CRISPR Cas Systems for Biosensing
by: Chung Chiun Liu, et al.
Published: (2023-06-01)

Signal stability of Cy3 and Cy5 on antibody microarrays
by: Kim Caroline, et al.
Published: (2006-10-01)

CRISPR-Cas-Based Engineering of Probiotics
by: Ling Liu, et al.
Published: (2023-01-01)

TRIM5α restricts poxviruses and is antagonized by CypA and viral protein C6
by: Zhao, Y, et al.
Published: (2023)

Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
by: Zhi-Ying Qi, et al.
Published: (2023-08-01)

New Insights into Dyskerin-CypA Interaction: Implications for X-Linked Dyskeratosis Congenita and Beyond
by: Valentina Belli, et al.
Published: (2023-09-01)

RETRACTED ARTICLE: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
by: Zhi-Ying Qi, et al.
Published: (2019-11-01)

Circulation immune cell landscape in canonical pathogenesis of colorectal adenocarcinoma by CyTOF analysis
by: Xiang-Xing Kong, et al.
Published: (2024-03-01)

CRISPR-Cas9/Cas12a biotechnology and application in bacteria
by: Ruilian Yao, et al.
Published: (2018-09-01)

Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
by: Wenjie Zhou, et al.
Published: (2021-02-01)

In silico Method in CRISPR/Cas System: An Expedite and Powerful Booster
by: Yuwei Zhang, et al.
Published: (2020-10-01)

CRISPR/Cas-based customization of pooled CRISPR libraries.
by: Jiyeon Kweon, et al.
Published: (2018-01-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism
by: Kun Zou, et al.
Published: (2015-08-01)

Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine
by: Mariarosaria Conte, et al.
Published: (2021-12-01)

CyTOF® for the Masses
by: Akshay Iyer, et al.
Published: (2022-04-01)

CRISPR-Cas-Integrated LAMP
by: Nazente Atçeken, et al.
Published: (2022-11-01)

A colorimetric, photothermal, and fluorescent triple-mode CRISPR/cas biosensor for drug-resistance bacteria detection
by: Laibao Zheng, et al.
Published: (2023-12-01)

Current advances of CRISPR-Cas technology in cell therapy
by: Hou-Yuan Qiu, et al.
Published: (2022-12-01)

Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017-05-01)

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
by: Roberto Gomez-Casal, et al.
Published: (2015-05-01)

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
by: Shuying Feng, et al.
Published: (2022-02-01)